Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Tumors of the gastrointestinal system represent a significant share of solid tumors worldwide. Despite the advances in diagnosis and treatment, the prognosis of gastrointestinal tumors is still very poor and improved therapies are indispensable. Cytokine-induced killer (CIK) cells are feasible for a...

Full description

Bibliographic Details
Main Authors:	Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/897214

Similar Items

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
by: Clara E. Jäkel, et al.
Published: (2012-01-01)

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
by: Ying Zhang, et al.
Published: (2020-09-01)

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
by: Francesca Garofano, et al.
Published: (2019-09-01)

Cytokine-induced killer cells are type II natural killer T cells
by: Schmidt-Wolf, Ingo G.H., et al.
Published: (2007-09-01)

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells
by: Rombo, Roman, et al.
Published: (2016-04-01)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
by: Hansong Du, et al.
Published: (2020-04-01)

High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
by: Francesca Garofano, et al.
Published: (2020-05-01)

Increased Efficacy of Brentuximab Vedotin (SGN-35) in Combination with Cytokine-Induced Killer Cells in Lymphoma
by: Laura Esser, et al.
Published: (2016-07-01)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
by: Xiaolong Wu, et al.
Published: (2020-07-01)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
by: Mojgan Naghizadeh Dehno, et al.
Published: (2020-04-01)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
by: Dario Sangiolo
Published: (2011-01-01)

Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
by: Claudia Schlimper, et al.
Published: (2012-01-01)

Evaluation on the Clinical Efficacy of Dendritic Cell-Activated Cytokine-Induced Killer Cells Combined with Conventional Therapy in the Treatment of Malignant Tumors
by: Hong WEI, et al.
Published: (2016-06-01)

Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
by: Schöttker, Björn, et al.
Published: (2011-01-01)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
by: Liu Y, et al.
Published: (2017-03-01)

Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells
by: Melanie Bremm, et al.
Published: (2019-05-01)

A clinical study of autologous cytokine-induced killer cells in treatment of patients with chronic hepatitis B
by: WANG Shaoyang
Published: (2015-04-01)

Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
by: Gianfranco ePittari, et al.
Published: (2015-05-01)

Cytokine-induced killer cells: A novel treatment for allergic airway inflammation.
by: Panwadee Pluangnooch, et al.
Published: (2017-01-01)

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
by: Xingchun Gao, et al.
Published: (2017-07-01)

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
by: Xiaolong Wu, et al.
Published: (2021-10-01)

Characterization of the natural killer cell cytokine response to antibody-coated tumor cells
by: Parihar, Robin
Published: (2004)

Progress in clinical follow-up study of dendritic cells combined with cytokine-induced killer for stomach cancer
by: Ling Wang, et al.
Published: (2019-01-01)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
by: Silvia Gaggero, et al.
Published: (2021-01-01)

Establishment of Adoptive Immunotherapy Transfusion Time of Cytokine-induced Killer Cells
by: Changping Wu, et al.
Published: (2013-09-01)

Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
by: Lu Han, et al.
Published: (2016-01-01)

Cytokines and cytokine therapy in gastrointestinal diseases
by: Т М Tsaregorodtseva, et al.
Published: (2004-04-01)

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
by: Yang Yang, et al.
Published: (2021-01-01)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
by: Michael Nowak, et al.
Published: (2011-09-01)

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus.
by: Xing Zhao, et al.
Published: (2017-01-01)

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells
by: Qingming Guo, et al.
Published: (2017-03-01)

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.
by: Zhi Yang, et al.
Published: (2012-01-01)

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
by: May Sabry, et al.
Published: (2019-01-01)

Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
by: Zhang Y, et al.
Published: (2017-09-01)

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
by: Corallo Maria, et al.
Published: (2010-12-01)

Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
by: Min Wang, et al.
Published: (2014-01-01)

Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
by: Daiqing Gao, et al.
Published: (2014-01-01)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
by: Ma Yue, et al.
Published: (2012-04-01)

Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus.
by: Xing Zhao, et al.
Published: (2018-01-01)